Welcome to LookChem.com Sign In|Join Free

CAS

  • or

51686-78-3

Post Buying Request

51686-78-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51686-78-3 Usage

Chemical Properties

Light yellow powder

Check Digit Verification of cas no

The CAS Registry Mumber 51686-78-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,6,8 and 6 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 51686-78:
(7*5)+(6*1)+(5*6)+(4*8)+(3*6)+(2*7)+(1*8)=143
143 % 10 = 3
So 51686-78-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H3Br2NO2/c7-4-1-2-6(9(10)11)5(8)3-4/h1-3H

51686-78-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H61738)  1,3-Dibromo-4-nitrobenzene, 98%   

  • 51686-78-3

  • 250mg

  • 424.0CNY

  • Detail
  • Alfa Aesar

  • (H61738)  1,3-Dibromo-4-nitrobenzene, 98%   

  • 51686-78-3

  • 1g

  • 1271.0CNY

  • Detail
  • Alfa Aesar

  • (H61738)  1,3-Dibromo-4-nitrobenzene, 98%   

  • 51686-78-3

  • 5g

  • 5086.0CNY

  • Detail

51686-78-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4-Dibromo-1-nitrobenzene

1.2 Other means of identification

Product number -
Other names 2,4-dibromo-1-nitrobenzene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51686-78-3 SDS

51686-78-3Relevant articles and documents

Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38α MAP kinase inhibitors with excellent in vivo antiinflammatory properties

Mader, Mary,de Dios, Alfonso,Shih, Chuan,Bonjouklian, Rosanne,Li, Tiechao,White, Wesley,de Uralde, Beatriz Lopez,Sanchez-Martinez, Concepcion,del Prado, Miriam,Jaramillo, Carlos,de Diego, Eugenio,Martin Cabrejas, Luisa M.,Dominguez, Carmen,Montero, Carlos,Shepherd, Timothy,Dally, Robert,Toth, John E.,Chatterjee, Arindam,Pleite, Sehila,Blanco-Urgoiti, Jaime,Perez, Leticia,Barberis, Mario,Lorite, Maria Jose,Jambrina, Enrique,Nevill Jr., C. Richard,Lee, Paul A.,Schultz, Richard C.,Wolos, Jeffrey A.,Li, Li C.,Campbell, Robert M.,Anderson, Bryan D.

, p. 179 - 183 (2008)

Herein we report investigations into the p38α MAP kinase activity of trisubstituted imidazoles that led to the identification of compounds possessing highly potent in vivo activity. The SAR of a novel series of imidazopyridines is demonstrated as well, resulting in compounds possessing cellular potency and enhanced in vivo activity in the rat collagen-induced arthritis model of chronic inflammation.

Synthesis and: In vitro evaluation of naphthalimide-benzimidazole conjugates as potential antitumor agents

Singh, Iqubal,Luxami, Vijay,Paul, Kamaldeep

, p. 5349 - 5366 (2019/06/07)

A series of novel naphthalimide-benzimidazoles was designed and synthesized for the first time and studied for their effect on antiproliferative activity. Some of these compounds possessed good antitumor activity towards the tested cancer cell lines. Noticeably, (diethylamino)ethyl 15 and (dimethylamino)ethyl 23 derivatives displayed superior antiproliferative activity towards human cancer cell lines with MG-MID GI50 values of 1.43 and 1.83 μM, respectively. Preliminary investigation revealed that compounds 15 and 23 might bind with ct-DNA through the intercalation mode which is responsible for potent bioactivity. Moreover, transportation behaviour indicated that these molecules could efficiently bind to and be carried by bovine albumin, and the hydrogen bonding and hydrophobic interactions played important roles in interaction with serum albumin.

ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME

-

Paragraph 0135; 0136, (2018/05/24)

The present invention provides an organic compound for an organic light emitting diode. An example of the organic compound is represented by:

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51686-78-3